A meta-analysis of the antiviral activity of the HBV-specific immunotherapeutic TG1050 confirms its value over a wide range of HBsAg levels in a persistent HBV pre-clinical model

por Kratzer, Roland, Sansas, Benoît, Lélu, Karine, Evlachev, Alexei, Schmitt, Doris, Silvestre, Nathalie, Inchauspé, Geneviève, Martin, Perrine
Publicado 2018

Sequential administration of MVA-based vaccines and PD-1/PD-L1-blocking antibodies confers measurable benefits on tumor growth and survival: Preclinical studies with MVA-βGal and M...

por Remy-Ziller, Christelle, Thioudellet, Christine, Hortelano, Julie, Gantzer, Murielle, Nourtier, Virginie, Claudepierre, Marie-Christine, Sansas, Benoit, Préville, Xavier, Bendjama, Kaïdre, Quemeneur, Eric, Rittner, Karola
Publicado 2017

Safety and immunogenicity of the therapeutic vaccine TG1050 in chronic hepatitis B patients: a phase 1b placebo-controlled trial

por Zoulim, Fabien, Fournier, Claire, Habersetzer, François, Sprinzl, Martin, Pol, Stanislas, Coffin, Carla S, Leroy, Vincent, Ma, Mang, Wedemeyer, Heiner, Lohse, Ansgar W, Thimme, Robert, Lugardon, Karine, Martin, Perrine, Bastien, Bérangère, Sansas, Benoit, Adda, Nathalie, Halluard, Celine, Bendjama, Kaïdre, Brandely, Maud, Inchauspé, Geneviève
Publicado 2019

A multi-antigenic MVA vaccine increases efficacy of combination chemotherapy against Mycobacterium tuberculosis

por Leung-Theung-Long, Stéphane, Coupet, Charles-Antoine, Gouanvic, Marie, Schmitt, Doris, Ray, Aurélie, Hoffmann, Chantal, Schultz, Huguette, Tyagi, Sandeep, Soni, Heena, Converse, Paul J., Arias, Lilibeth, Kleinpeter, Patricia, Sansas, Benoît, Mdluli, Khisimuzi, Vilaplana, Cristina, Cardona, Pere-Joan, Nuermberger, Eric, Marchand, Jean-Baptiste, Silvestre, Nathalie, Inchauspé, Geneviève
Publicado 2018